As the landscape of HIV treatment continues to evolve, injectable antiretroviral therapy (ART) is gaining significant traction in Australia.
Long Lasting
Cabenuva is the latest innovation in HIV medication. It consists of long-acting injections that last 2 months at a time, after the introduction phase.
How to start
There are two ways to start the new treatment. You can take an oral version for 28 days or go directly to receiving long-acting injections. Your doctor will help decide which option is best for you.
Effectiveness
Research shows that injectable treatments are just as effective as traditional oral medications, helping individuals maintain an undetectable viral load and preventing transmission.
Lifestyle
The shift to injectable ART can simplify treatment regimens. Those who have made the switch reported benefits such as reduced stigma associated with visible medication, removing the daily reminder of the virus, the need to stock and travel with medication and issues with ingesting tablets.
Suitability
Is cabenuva right for you?
The new treatment is complex and may not suit everyone. It can require more visits to your healthcare professional to administer the injections, depending on the frequency. There are some minor side effects such as pain and swelling in the injection site. You must already have a suppressed viral load before you switch to injectables. Certain medications can interact with the new treatment, so you will need to check with your doctor to make sure cabenuva is right for you.
Find out more:
